YH4808

DRUG4 trials

Sponsors

Yuhan Corporation

Conditions

Healthy

Phase 1

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

CompletedNCT01007019

Yuhan CorporationHealthy

Start: 2009-11-30End: 2012-03-31Updated: 2014-07-10

YH4808 Postprandial PK/PD Study in Healthy Subjects

CompletedNCT01761513

Yuhan CorporationHealthy

Start: 2012-11-30End: 2014-02-28Updated: 2014-04-15

Pharmacokinetic Drug Interaction Between YH4808 and Diclofenac

CompletedNCT01876615

Yuhan CorporationHealthy

Start: 2013-07-31End: 2013-12-31Updated: 2014-01-01

The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

CompletedNCT01921647

Yuhan CorporationHealthy

Start: 2013-07-31End: 2013-11-30Updated: 2013-12-03

Related Papers

Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen

Translational and Clinical Pharmacology2021-01-011 citations

Pharmacodynamic evaluation of YH4808 for <i>Helicobacter pylori</i> eradication in healthy subjects

Translational and Clinical Pharmacology2020-01-017 citations

Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects

Translational and Clinical Pharmacology2020-01-015 citations